Gender gap in stroke treatment likely due to delay by women seeking care
Women with clot-caused strokes are less likely than men to arrive at the hospital in time to receive the best treatment, according to a European study reported in the American Heart Association journal Stroke. In the study, 11 percent of women with acute ischemic strokes were treated with the clot-dissolving medication alteplase, compared with 14 percent of men. Study participants included 5,515 patients at 12 hospitals in the Netherlands... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 29, 2013 Category: Consumer Health News Tags: Stroke Source Type: news
Alteplase Shows Lasting Benefit in Stroke SurvivorsAlteplase Shows Lasting Benefit in Stroke Survivors
Thrombolysis with alteplase has long-term benefits after stroke, although longer survival isn't among them. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 5, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Alteplase use linked to reduction in disability after stroke
Few patients receive the drug, but could it cut long-term costs of stroke care?Related items from OnMedicaRisk/benefit balance of alteplase shifts quicklyEarlier thrombolysis improves stroke outcomesStatin use after stroke not linked to bleedsAvoid BP-lowering drugs in strokeNew guidance to prevent strokes (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 21, 2013 Category: UK Health Source Type: news
